S2P-NDVLP was localized in the ~50% sucrose fraction, detected by immunoblotting assay with anti-SARS-CoV-2 sera obtained from COVID-19 patients or by VLP capture ELISA with the neutralizing antibody S652-118 (Figure S1A,B). The gene discussed is MBTPS2; the disease is COVID-19.